Stabilizers, Silencers, and Disease Stage: Lessons From Recent Trials of ATTR Cardiac Amyloidosis.

Saved in:
Bibliographic Details
Title: Stabilizers, Silencers, and Disease Stage: Lessons From Recent Trials of ATTR Cardiac Amyloidosis.
Authors: Siddiqi HK; Department of Medicine, Division of Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Bhatt K; Department of Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, USA., Gopal DM; Department of Medicine, Section of Cardiovascular Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts, USA; Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA., Siddiqi OK; Department of Medicine, Section of Cardiovascular Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts, USA; Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA. Electronic address: omar.siddiqi@bmc.org.
Source: Journal of the American College of Cardiology [J Am Coll Cardiol] 2026 Feb 10; Vol. 87 (5), pp. 502-504. Date of Electronic Publication: 2025 Dec 03.
Publication Type: Editorial
Journal Info: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1558-3597
DOI:10.1016/j.jacc.2025.10.019